Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Opportunity Pathways - GLP-1 Diabetes Treatment Drugs Market The GLP-1 diabetes treatment drugs market represents one of the most explosive pharmaceutical opportunities of the decade, with the market projected to surge from USD 6,556.5 million in 2025 to USD 62,543.2 million by 2035 at an extraordinary 25.3% CAGRa 9.5X expansion driven by the global diabetes epidemic, breakthrough efficacy data, and expanding therapeutic applications beyond glucose control to include weight management and cardiovascular protection
& Gouet, P
The up-regulation of plant GST genes as a consequence of bacterium-induced oxidative stress was early recognized
Packaged in an air-sealed mylar bag
Kosower NS, Kosower EM
26 Clinical data on GLP-1 receptor agonists and pancreatitis occurrence Postlethwaite, et al 7 reported that, among 2,245 patients with obesity (mean body mass index 39.7 kg/m2 ) who started GLP-1 receptor agonist therapy, 49 (2.2%) developed acute pancreatitis
